| Literature DB >> 35147676 |
Pengfei Zhu1, Xudong Xu1, Bo Ye1, Guocan Yu1, Likui Fang1, Wenfeng Yu1, Fangming Zhong1, Xiaowei Qiu2, Xin Yang2.
Abstract
OBJECTIVES: The goal of this study was to develop and validate a nomogram for predicting residual cavity formation after video-assisted thoracoscopic decortication in patients with chronic tuberculous empyema (CTE).Entities:
Keywords: chronic tuberculous empyema; decortication; nomogram; risk factors
Mesh:
Year: 2022 PMID: 35147676 PMCID: PMC9070475 DOI: 10.1093/icvts/ivac011
Source DB: PubMed Journal: Interact Cardiovasc Thorac Surg ISSN: 1569-9285
Figure 1:Flow chart of patients with chronic tuberculous empyema enrolled from our hospital from January 2017 to December 2020. Based on the inclusion and exclusion criteria, 103 patients were included in this study. PRCF: postoperative residual cavity formation.
Baseline characteristics of patients in the postoperative residual cavity formation or no postoperative residual cavity formation groups
| Variables | Postoperative residual cavity | P value | |
|---|---|---|---|
| Yes (N = 30) | No (N = 73) | ||
| Sex | |||
| Male | 26 (86.7%) | 46 (63%) | |
| Female | 4(13.3%) | 27(37%) | |
| Age, years | 40 ± 15.9 | 33.7 ± 16.5 | 0.078 |
| Clinical characteristics | |||
| Cough | 13(43.3%) | 28(38.4%) | |
| Dyspnoea | 11(36.7%) | 22(30.2%) | |
| Chest pain | 4(13.3%) | 7(9.5%) | |
| Fever | 2(6.7%) | 16(21.9%) | |
| MAP, mmHg | 87 ± 12 | 88.6 ± 10 | 0.499 |
| Heart rate, beats/min | 85.2 ± 10.7 | 82.1 ± 10.9 | 0.19 |
| WBC, *109/l | 5.8 ± 1.9 | 5.3 ± 1.7 | 0.288 |
| Creatinine, μmol/l | 77.2 ± 10.2 | 77.2 ± 13.5 | 0.983 |
| Albumin, g/l | 39 ± 6.5 | 40.2 ± 5.6 | 0.363 |
| CRP, cm H2o | 26.4 ± 45.1 | 13.4 ± 24.6 | 0.144 |
| FEV1, L | 2 ± 0.6 | 2.2 ± 0.5 | 0.092 |
| LVEF, % | 63.2 ± 6.7 | 63.4 ± 4.5 | 0.799 |
| Lactate, mmol/l | 1.2 ± 0.3 | 1.3 ± 0.5 | 0.473 |
| Treatment time of TB, months | 8.4 ± 6.9 | 9.3 ± 5.3 | 0.509 |
| Complicated with PTB | 11(36.7%) | 42(57.5%) | 0.189 |
| Area, cm² | 220.65 ± 86.44 | 125.97 ± 69.53 | <0.01 |
| Calcification | 18(60%) | 9(12.3%) | <0.01 |
| Thickness, mm | 11.6 ± 3.7 | 7.1 ± 3.4 | <0.01 |
| Duration of symptoms, months | 11.2 ± 15.2 | 17 ± 43 | 0.318 |
CRP: C-reactive protein; FEV1: forced expiratory volume in 1 s; LVEF: left ventricular ejection fraction (measured via echocardiogram); MAP: mean arterial pressure; PTB: pulmonary tuberculosis; TB: tuberculosis; WBC: white blood cells.
Comparison of postoperative outcomes between the postoperative residual cavity formation and the no postoperative residual cavity formation groups
| Characteristics | Postoperative residual cavity | p Value | |
|---|---|---|---|
| Yes (N = 30) | No (N = 73) | ||
| Duration of the surgery, h | 3.53 ± 1.3 | 2.98 ± 1.26 | 0.049 |
| Extubation time, days | 13.83 ± 5.26 | 12.29 ± 5.39 | 0.184 |
| Postoperative hospital stay, days | 16.63 ± 7.58 | 12.36 ± 5.43 | 0.008 |
| In-hospital deaths | 0 | 0 | … |
| 90-Day deaths | 0 | 0 | … |
| Conversion to thoracotomy | 4 (13.3%) | 2 (2.7%) | 0.105 |
Univariable and multivariable analyses of factors associated with the formation of a postoperative residual cavity
| Variables | Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| P value | OR | 95% CI | P value | OR | 95% CI | |
| Age | 0.081 | 1.023 | 0.997-1.05 | 0.446 | 1.016 | 0.976-1.057 |
| CRP | 0.089 | 1.012 | 0.998-1.025 | 0.643 | 1.005 | 0.985-1.025 |
| FEV1 | 0.095 | 0.482 | 0.204-1.137 | 0.536 | 0.658 | 0.174-2.481 |
| Area | <0.01 | 1.015 | 1.008-1.022 | 0.001 | 1.017 | 1.007-1.028 |
| Calcification | <0.01 | 0.108 | 0.039-0.294 | 0.004 | 0.12 | 0.029-0.501 |
| Duration of the operation, h | 0.054 | 1.394 | 0.995-1.953 | 0.255 | 0.674 | 0.341-1.329 |
| Thickness | <0.01 | 1.448 | 1.222-1.716 | 0.02 | 1.315 | 1.045-1.654 |
CRP: C-reactive protein; FEV1: forced expiratory volume in 1 s.
Figure 2:Nomogram for predicting the risk of residual cavity formation after video-assisted thoracoscopic decortication in chronic tuberculous empyema. Thickness: thickness of pleura; area:—the contact area between the lung and the empyema; calcification: pleural calcification.
Scoring system for predicting postoperative residual cavity formation
| Predictors | Scores |
|---|---|
| Calcification | |
| No | 37 |
| Yes | 72 |
| Thickness (mm) | |
| 2 | 13 |
| 4 | 20 |
| 6 | 28 |
| 8 | 35 |
| 10 | 43 |
| 12 | 50 |
| 14 | 58 |
| 16 | 65 |
| 18 | 73 |
| 20 | 80 |
| 22 | 88 |
| 24 | 95 |
| Area (cm2) | |
| 0 | −2 |
| 50 | 10 |
| 100 | 23 |
| 150 | 36 |
| 200 | 49 |
| 250 | 61 |
| 300 | 74 |
| 350 | 87 |
| 400 | 100 |
| Total | 267 |
| Atelectasis rate | |
| 0.00028 | 0 |
| 0.00481 | 50 |
| 0.07699 | 100 |
| 0.59010 | 150 |
| 0.96130 | 200 |
| 0.99770 | 250 |
| 0.99990 | 300 |
Thickness: thickness of pleura; area: the contact area between lung and empyema; calcification: pleural calcification.
Diagnostic performance of each predictive factor and overall model
| Variables | Cut-off | AUC | OR (95% CI) | P Value | Sensitivity | Specificity |
|---|---|---|---|---|---|---|
| Area (cm2) | 186.46 | 0.795 | 0.703-0.888 | <0.01 | 63.33 | 86.3 |
| Thickness | 8.75 | 0.822 | 0.742-0.903 | <0.01 | 86.7 | 71.2 |
| Calcification | ||||||
| YES | 0.722 | 0.604-0.84 | <0.01 | 60 | 87.7 | |
| NO | Reference | |||||
| Nomogram | 0.891 | 0.82-0.963 | <0.01 | 86.67 | 82.19 |
Thickness: thickness of pleura.
Area: the contact area between the lung and the empyema.
Calcification: calcification of the pleura.
AUC: area under curve; OR: odd ratio.
Figure 3:(A) Receiver operating characteristic curve of the nomogram. (B) Calibration curve for the nomogram.